Literature DB >> 28322462

STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt.

Xingwen Zhang1,2, Xiang Li2, Fengbo Tan1, Nanhui Yu1, Haiping Pei1.   

Abstract

Signal transducers and activators of transcription 1 (STAT1) exhibits tumor-suppressor properties by inhibiting oncogenic pathways and promoting tumor immunosurveillance. MicroRNAs, a group of non-coding endogenous ones, may regulate gene expression and plays specific roles in tumorigenesis. Recently, miR-181a has been reported to be associated with poor prognosis of colorectal cancer (CRC). Using human colorectal cancer cell lines, we demonstrated that STAT1 suppresses both LoVo and SW480 cell growth by down-regulating miR-181a. STAT1 regulates the expression of miR-181a through binding to the elements in the miR-181a's promoter region. Further, we revealed that miR-181a accelerates CRC cell proliferation through phosphatase and tensin homolog on chromosome ten (PTEN). In addition, PTEN protein was upregulated in response to STAT1 overexpression or miR-181a inhibition, downregulated in response to STAT1 knockdown or miR-181a overexpression. Without changes on the AKT protein level, p-AKT was downregulated by STAT1 overexpression or miR-181a inhibition while upregulated by STAT1 knockdown or miR-181a overexpression, indicating PTEN/Akt pathway activated in STAT1/miR-181a regulation of CRC cell proliferation. Taken together, our findings shed new light on the STAT1/miR-181a/PTEN pathway in colorectal cancer and add new insight regarding the carcinogenesis of colorectal cancer. J. Cell. Biochem. 118: 3435-3443, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT; COLORECTAL CANCER; PTEN; STAT1; miR-181a

Mesh:

Substances:

Year:  2017        PMID: 28322462     DOI: 10.1002/jcb.26000

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

1.  STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.

Authors:  Nathan Ryan; Kelvin Anderson; Greta Volpedo; Omar Hamza; Sanjay Varikuti; Abhay R Satoskar; Steve Oghumu
Journal:  Int J Cancer       Date:  2019-11-29       Impact factor: 7.396

2.  The lncRNA MIAT/miR-181a-5p axis regulates osteopontin (OPN)-mediated proliferation and apoptosis of human chondrocytes in osteoarthritis.

Authors:  Suolin Zeng; Min Tu
Journal:  J Mol Histol       Date:  2022-03-14       Impact factor: 2.611

3.  MicroRNA-513a-3p regulates colorectal cancer cell metabolism via targeting hexokinase 2.

Authors:  Chen Li; Zhijin Yu; Jinpeng Ye
Journal:  Exp Ther Med       Date:  2020-05-07       Impact factor: 2.447

Review 4.  Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.

Authors:  Zeinab Moafian; Abolfazl Maghrouni; Arash Soltani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2021-05-31       Impact factor: 2.316

Review 5.  NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging.

Authors:  Víctor Micó; Laura Berninches; Javier Tapia; Lidia Daimiel
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

6.  MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway.

Authors:  Wu Sun; Xiaojun Wang; Jialu Li; Chaoying You; Pan Lu; Huijin Feng; Yan Kong; Haiyang Zhang; Yanqing Liu; Ruihua Jiao; Xi Chen; Yi Ba
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

7.  Predicting STAT1 as a prognostic marker in patients with solid cancer.

Authors:  Jinguo Zhang; Fanchen Wang; Fangran Liu; Guoxiong Xu
Journal:  Ther Adv Med Oncol       Date:  2020-05-08       Impact factor: 8.168

8.  Identification of microRNA-181 as a promising biomarker for predicting the poor survival in colorectal cancer.

Authors:  Qiliang Peng; Wenyan Yao; Chenxiao Yu; Li Zou; Yuntian Shen; Yaqun Zhu; Ming Cheng; Zhengyang Feng; Bo Xu
Journal:  Cancer Med       Date:  2019-08-25       Impact factor: 4.452

9.  The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer.

Authors:  Kei Nakamura; Atsushi Shiozaki; Toshiyuki Kosuga; Hiroki Shimizu; Michihiro Kudou; Takuma Ohashi; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Eigo Otsuji
Journal:  Gastric Cancer       Date:  2021-07-12       Impact factor: 7.701

10.  Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis.

Authors:  Tengda Li; Mingli Gu; Anmei Deng; Cheng Qian
Journal:  Cancer Cell Int       Date:  2020-06-15       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.